2004
DOI: 10.3748/wjg.v10.i15.2209
|View full text |Cite
|
Sign up to set email alerts
|

Natural history of chronic hepatitis C in patients on hemodialysis: Case control study with 4-23 years of follow-up

Abstract: AIM: Hepatitis C virus (HCV) infection is very common among end-stage kidney disease patients on hemodialysis, but its natural history is not known. METHODS:In this study, 189 dialysis patients (case) positive for HCV antibodies who were followed up for more than 4 years were compared with twice as many sex/age matched controls with chronic hepatitis C who were diagnosed in the same month as the case and followed up for comparable periods. The longest follow-up was 23 years in dialysis cases. The disease activ… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
24
0

Year Published

2005
2005
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 35 publications
(24 citation statements)
references
References 22 publications
0
24
0
Order By: Relevance
“…59 Others at risk for more rapid fi brosis progression include individuals coinfected with HIV, 60 individuals with hypogammaglobulinemia infected by HCVcontaminated IV immunoglobulin, 61 and liver transplant recipients. 62,63 Groups associated with mild/moderate HCV-induced liver fi brosis include children infected in utero by HCV-infected mothers and those infected in childhood, [64][65][66] hemophiliacs infected by contaminated blood clotting factors, 67 individuals undergoing hemo dialysis, 68 women infected at young ages with contaminated anti-D immune globulin, 69 and women aged 20 years or less when infected through blood transfusion and others similarly affected. 70,71 Evaluation of the immunologic characteristics of these patient groups and studies of the characteristics of the associated viral strains (e.g., quasispecies variability) may provide clues to the mechanisms of HCV-induced disease progression.…”
Section: Risk Factors For Fi Brosis Progressionmentioning
confidence: 99%
“…59 Others at risk for more rapid fi brosis progression include individuals coinfected with HIV, 60 individuals with hypogammaglobulinemia infected by HCVcontaminated IV immunoglobulin, 61 and liver transplant recipients. 62,63 Groups associated with mild/moderate HCV-induced liver fi brosis include children infected in utero by HCV-infected mothers and those infected in childhood, [64][65][66] hemophiliacs infected by contaminated blood clotting factors, 67 individuals undergoing hemo dialysis, 68 women infected at young ages with contaminated anti-D immune globulin, 69 and women aged 20 years or less when infected through blood transfusion and others similarly affected. 70,71 Evaluation of the immunologic characteristics of these patient groups and studies of the characteristics of the associated viral strains (e.g., quasispecies variability) may provide clues to the mechanisms of HCV-induced disease progression.…”
Section: Risk Factors For Fi Brosis Progressionmentioning
confidence: 99%
“…Although ribavirin may potentially be highly toxic in patients undergoing haemodialysis [1], and preliminary evidence suggests that hepatitis C is a mild and slowly progressing disease in this patient population [2], more consistent data indicate that not treating patients who are to undergo renal transplantation may lead to an increased risk of hepatitis C virus (HCV)-mediated allograft nephropathy [3,4], progression of liver disease [5], and diabetes [6]. For this 0168 The authors who have taken part in this study declared that they have no relationship with the manufacturers of the drugs involved either in the past or present and did not receive funding from the manufacturers to carry out their research.…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of HCV infection in these patients considerably exceeds the prevalence recorded in the general population, reaching up to 91% according to some reports [3, 4]. The natural course of the disease in this patient population is as a rule less severe than in patients with normal renal function, which is explained by the altered immune reaction in the presence of uremia and lower viremia that probably results from mechanical destruction of the virus on dialysis membrane [5,6,7]. Yet, a HCV infection during the course of HD should be properly treated because of generally higher mortality observed in these patients compared to HCV-negative dialysis patients and possible progression of untreated hepatic disease during the treatment with immunosuppressants following kidney transplantation [8,9,10,11].…”
Section: Introductionmentioning
confidence: 99%